20 May 2013
Keywords: biocryst/roche, psoriasis, drug, enters, ph, ii, alabama
Article | 23 July 2007
Alabama, USA-based BioCryst Pharmaceuticals and Swiss drug major Roche have initiated the first Phase II study to evaluate their co-developed
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 July 2007
17 May 2013
© 2013 thepharmaletter.com